1988. When this core was initiated, our main purpose was to support cloning and sequencing efforts of Liver Center Investigators. With the advent of PCR, the focus of the Core switched to production of high quality oligonucleotide primers and TAQ Polymerase. 1993. cDNA microarray technology was in its early stages of development. Realizing the impact that the cDNA approach to transcriptiome analysis would have on scientific investigation, the emphasis of the Core was focused on bringing cDNA microarray technologies into active use in the Liver Center. The Molecular Genetics Department took a leading role in developing one of the first cDNA microarray facilities in the country that produced high quality microarrays at a very reasonable price for AECOM Investigators. The Molecular Biology and Genetics Core was the first facility at Einstein to offer a full service for cDNA microarray technology that also included bioinformatics assistance. 1998. A state of the art computer workstation with all available programs for processing genomics transcriptome data was established and maintained by the Core Manager. cDNA microarray or Affymetrix oligonucleotide arrays were being utilized by at least 13 Liver Center Investigators. These included the laboratories of Drs David Shafritz, Mariana Dabeva, Mark Czaja, Leslie Rogler, Charles Rogler, David Cohen, Sanjeev Gupta, Liang Zhu, Robert Burk, J. Roy-Chowdhury, Luciano Rossetti, Michael Lisanti, and Irving Listowsky. 2002. The emphasis advanced beyond the mechanics of doing cDNA microarrays toward quantitative real-time PCR with the purchase an ABI Prism 7000 Sequence Detection System. This has become a workhorse machine for Center Investigators to confirm microarray data and analyze gene expression. Drs. Charles Rogler, Tatyana Tchaikovskaya and Mr. Christopher Plescia invented RNA expression microarray (REM) technology. REMs are a reverse microarray that spots cDNAs from many tissues on a single slide and can be used to assay the expression of a test gene across up to 1000's of tissue cDNAs on the slide simultaneously. This technology is now patent pending. 2005. MicroRNA research emphasis. Realizing the upcoming need for miRNA research, in 2005, Dr. Rogler headed an effort in the Core to develop a new microarray platform designed to carry out miRNA profiling (miRGEMs). In an effort to move into miRNA research, Dr. Rogler took a sabbatical leave in the Tuschl laboratory at Rockefeller University, where he learned miRNA cloning technology and helped develop miRNA target identification protocols. The miRGEMs are in their third printing, having been extensively used at Einstein. Current. The development of technologies for deep sequencing and other genomic analysis methods, (454 Life Sciences, Solexa and SNP analysis), have opened up a new era in genomics research. The current emphasis of the Core is to facilitate the use of these new technologies among Center Investigators by providing help and direction in the preparation of samples for sequencing and proteomic analysis, as illustrated in the list of Core services for the new grant period.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Liu, Zhongbo; Apontes, Pasha; Fomenko, Ekaterina V et al. (2018) Mangiferin Accelerates Glycolysis and Enhances Mitochondrial Bioenergetics. Int J Mol Sci 19:
Tekirdag, Kumsal; Cuervo, Ana Maria (2018) Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J Biol Chem 293:5414-5424
Zhao, Rongbao; Najmi, Mitra; Aluri, Srinivas et al. (2018) Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer. Mol Pharmacol 93:208-215
Amengual, Jaume; Guo, Liang; Strong, Alanna et al. (2018) Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100. Circ Res 122:568-582
Schneider, Michael; Kumar, Vivek; Nordstrøm, Lars Ulrik et al. (2018) Inhibition of Delta-induced Notch signaling using fucose analogs. Nat Chem Biol 14:65-71
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Galsgaard, Katrine D; Winther-Sørensen, Marie; Ørskov, Cathrine et al. (2018) Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis. Am J Physiol Endocrinol Metab 314:E93-E103
Shen, Ling; Liu, Yin; Tso, Patrick et al. (2018) Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression. J Biol Chem 293:2091-2101
Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642
Kakabadze, Zurab; Kakabadze, Ann; Chakhunashvili, David et al. (2018) Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure. Hepatology 67:1956-1969

Showing the most recent 10 out of 451 publications